Research programme: BIRC3 protein inhibitors - Pharmascience
Alternative Names: AEG 3373; BIRC3 antisense therapy; HIAP-1 antisense therapy; HIAP-1 inhibitorsLatest Information Update: 05 Mar 2007
At a glance
- Originator Aegera Therapeutics
- Class
- Mechanism of Action Apoptosis stimulants; BIRC3 protein inhibitors; Inhibitor of apoptosis protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 05 Mar 2007 Discontinued - Preclinical for Cancer in Canada (Parenteral)
- 18 Nov 2004 Preclinical development is ongoing
- 26 Aug 2003 Preclinical trials in Cancer in Canada (Parenteral)